Gary Pratt

1.2k total citations
18 papers, 630 citations indexed

About

Gary Pratt is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, Gary Pratt has authored 18 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 7 papers in Pathology and Forensic Medicine and 7 papers in Neurology. Recurrent topics in Gary Pratt's work include Lymphoma Diagnosis and Treatment (7 papers), CNS Lymphoma Diagnosis and Treatment (6 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Gary Pratt is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), CNS Lymphoma Diagnosis and Treatment (6 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Gary Pratt collaborates with scholars based in Australia, New Zealand and United States. Gary Pratt's co-authors include Michael Bartoň, Daniel Roos, Michael Poulsen, Peter C. O’Brien, K.H. Liew, Ian Olver, G. Trotter, Scott Williams, Gillian Duchesne and Larry L. Kestin and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Gary Pratt

18 papers receiving 617 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary Pratt Australia 13 328 309 290 228 123 18 630
Ferial Shihadeh United States 10 329 1.0× 207 0.7× 124 0.4× 98 0.4× 255 2.1× 17 576
P Poortmans Netherlands 7 247 0.8× 186 0.6× 185 0.6× 120 0.5× 129 1.0× 21 428
George Quong Australia 13 168 0.5× 152 0.5× 365 1.3× 199 0.9× 163 1.3× 22 692
Timothy L. Thar United States 12 292 0.9× 191 0.6× 180 0.6× 158 0.7× 114 0.9× 18 600
Lisa Lowry United Kingdom 9 634 1.9× 229 0.7× 146 0.5× 162 0.7× 482 3.9× 19 763
Bhavani D. Nair Canada 6 193 0.6× 81 0.3× 153 0.5× 193 0.8× 198 1.6× 7 657
J M Burgers France 9 488 1.5× 121 0.4× 388 1.3× 80 0.4× 167 1.4× 10 706
Christian W. Scholz Germany 12 295 0.9× 120 0.4× 156 0.5× 140 0.6× 253 2.1× 38 544
Jane Myers United States 10 554 1.7× 212 0.7× 252 0.9× 138 0.6× 249 2.0× 15 614
A. Le Mevel France 8 310 0.9× 265 0.9× 89 0.3× 235 1.0× 159 1.3× 14 532

Countries citing papers authored by Gary Pratt

Since Specialization
Citations

This map shows the geographic impact of Gary Pratt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Pratt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Pratt more than expected).

Fields of papers citing papers by Gary Pratt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Pratt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Pratt. The network helps show where Gary Pratt may publish in the future.

Co-authorship network of co-authors of Gary Pratt

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Pratt. A scholar is included among the top collaborators of Gary Pratt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Pratt. Gary Pratt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Raithatha, Ajay, et al.. (2013). Developments in the management of acute ischaemic stroke: implications for anaesthetic and critical care management. Continuing Education in Anaesthesia Critical Care & Pain. 13(3). 80–86. 1 indexed citations
3.
Tripcony, Lee, et al.. (2013). A retrospective analysis of survival outcomes for two different radiotherapy fractionation schedules given in the same overall time for limited stage small cell lung cancer. Journal of Medical Imaging and Radiation Oncology. 57(1). 105–112. 14 indexed citations
4.
Fay, Michael, et al.. (2013). Recent advances in radiotherapy for thoracic tumours.. PubMed. 5 Suppl 5. S551–5. 5 indexed citations
5.
Christie, David, Keith Dear, Thai‐Ha Le, et al.. (2010). Limited Chemotherapy and Shrinking Field Radiotherapy for Osteolymphoma (Primary Bone Lymphoma): Results From the Trans-Tasman Radiation Oncology Group 99.04 and Australasian Leukaemia and Lymphoma Group LY02 Prospective Trial. International Journal of Radiation Oncology*Biology*Physics. 80(4). 1164–1170. 26 indexed citations
6.
Burmeister, B., D. Zarate, Elizabeth Burmeister, et al.. (2009). Lung cancer patients in Queensland suffer delays in receiving radiation therapy – but not as a result of distance. Internal Medicine Journal. 40(2). 126–132. 14 indexed citations
7.
Williams, Scott, Jeremy M. G. Taylor, Ning Liu, et al.. (2007). Use of Individual Fraction Size Data from 3756 Patients to Directly Determine the α/β Ratio of Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 68(1). 24–33. 119 indexed citations
8.
Williams, Scott, Gillian Duchesne, Nirdosh Kumar Gogna, et al.. (2006). An international multicenter study evaluating the impact of an alternative biochemical failure definition on the judgment of prostate cancer risk. International Journal of Radiation Oncology*Biology*Physics. 65(2). 351–357. 22 indexed citations
9.
Williams, Scott, Tom Pickles, Larry L. Kestin, et al.. (2006). A multicenter study demonstrating discordant results from electronic prostate-specific antigen biochemical failure calculation systems. International Journal of Radiation Oncology*Biology*Physics. 65(5). 1494–1500. 5 indexed citations
10.
Wirth, Andrew, Kally Yuen, Michael Bartoň, et al.. (2005). Long‐term outcome after radiotherapy alone for lymphocyte‐predominant Hodgkin lymphoma. Cancer. 104(6). 1221–1229. 61 indexed citations
11.
O’Brien, Peter C., Daniel Roos, Gary Pratt, et al.. (2005). Combined-modality therapy for primary central nervous system lymphoma: Long-term data from a Phase II multicenter study (Trans-Tasman Radiation Oncology Group). International Journal of Radiation Oncology*Biology*Physics. 64(2). 408–413. 70 indexed citations
12.
Fong, Kwun M., R. Abraham, Morgan Windsor, et al.. (2005). P-326 Queensland Integrated Lung Cancer Outcomes Project (QILCOP): 2000 – 2003. Lung Cancer. 49. S201–S201. 1 indexed citations
13.
Williams, Scott, Gillian Duchesne, Jeremy Millar, & Gary Pratt. (2004). Both pretreatment prostate-specific antigen level and posttreatment biochemical failure are independent predictors of overall survival after radiotherapy for prostate cancer. International Journal of Radiation Oncology*Biology*Physics. 60(4). 1082–1087. 23 indexed citations
14.
O’Brien, Peter C., Daniel Roos, Gary Pratt, et al.. (2000). Phase II Multicenter Study of Brief Single-Agent Methotrexate Followed by Irradiation in Primary CNS Lymphoma. Journal of Clinical Oncology. 18(3). 519–519. 187 indexed citations
15.
Christie, David, Michael Bartoň, Robyn Cheuk, et al.. (1999). Osteolymphoma (primary bone lymphoma): an Australian review of 70 cases. Australian and New Zealand Journal of Medicine. 29(2). 214–219. 23 indexed citations
16.
Bartoň, Michael, John Boyages, Susan R. Davis, et al.. (1996). Radiotherapy for early infradiaphragmatic Hodgkin's disease: the Australasian experience. Radiotherapy and Oncology. 39(1). 1–7. 12 indexed citations
17.
Bartoň, Michael, John Boyages, Sidney Davis, et al.. (1995). Radiation therapy for early stage Hodgkin's disease: Australasian patterns of care. International Journal of Radiation Oncology*Biology*Physics. 31(2). 227–236. 14 indexed citations
18.
Poulsen, Michael, et al.. (1992). Prognostic variables in malignant epithelial tumors of the parotid. International Journal of Radiation Oncology*Biology*Physics. 23(2). 327–332. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ferial Shihadeh Breakdown of academic impact, for papers by P Poortmans Breakdown of academic impact, for papers by George Quong Breakdown of academic impact, for papers by Timothy L. Thar Breakdown of academic impact, for papers by Lisa Lowry Breakdown of academic impact, for papers by Bhavani D. Nair Breakdown of academic impact, for papers by J M Burgers Breakdown of academic impact, for papers by Christian W. Scholz Breakdown of academic impact, for papers by Jane Myers Breakdown of academic impact, for papers by A. Le Mevel
Rankless by CCL
2026